Focal Therapeutics Release: BioZorb Surgical Marker Provides New Tool For Breast Cancer Patients

Published: Nov 22, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PORTOLA VALLEY, Calif.--(BUSINESS WIRE)--Focal Therapeutics announced that its BioZorb™ three-dimensional tissue marker has now been successfully used in over 100 patients – marking a significant milestone for the company and the field of post-surgical radiation treatment for breast cancer.

Help employers find you! Check out all the jobs and post your resume.

Back to news